https://respiratory-research.biomedcentral.com/articles/10.1186/s12931-020-01347-7 https://www.ncbi.nlm.nih.gov/pubmed/32907566?dopt=Abstract Navafenterol (AZD8871) in patients with COPD: a randomized, double-blind, phase I study evaluating safety and pharmacodynamics of single doses of this novel, inhaled, long-acting, dual-pharmacology bronchodilator. Navafenterol (AZD8871) in patients with COPD: a randomized, double-blind, phase I study evaluating safety and pharmacodynamics of single doses of this novel, inhaled, long-acting, dual-pharmacology bronchodilator. Respir […]